• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Vertex Pharmaceuticals

layoffs
Biotech

Vertex consolidates Rhode Island footprint, cuts 125 jobs

The company is merging its three buildings at its Providence campus into one and leaving behind 125 staffers after a recent phase 1/2 fail.
Zoey Becker Jun 11, 2025 10:38am
Illustration connected puzzle pieces with the acronym MA

Lilly lands next-gen pain asset in $1B SiteOne acquisition

May 27, 2025 11:30am
pause button on blue background

Vertex takes $379M hit tied to cancelled islet cell program

May 6, 2025 12:50pm
AAV virus capsid

Vertex discontinues AAV research for gene therapies

May 2, 2025 6:22pm
Vertex

Vertex drops cell-device diabetes combo over poor ph. 1 results

Mar 31, 2025 4:20am
u turn turnaround return

Vertex axes Verve gene editing pact amid shift in R&D priorities

Feb 27, 2025 9:05am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings